TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS Trademark

Trademark Overview

On Friday, November 4, 2016, a trademark application was filed for TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS with the United States Patent and Trademark Office. The USPTO has given the TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark a serial number of 87227314. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 12, 2024. This trademark is owned by Gilead Sciences, Inc.. The TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting public awareness on the prevention of HIV infection

Medical services, namely, providing information regarding the prevention of HIV infection
truvada emtricitabine 200 mg / tenofovir disoproxil fumarate 300 mg tablets for prep pre-exposure prophylaxis

General Information

Serial Number87227314
Word MarkTRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Filing DateFriday, November 4, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 12, 2024
Registration Number5623246
Registration DateTuesday, December 4, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Description of MarkThe mark consists of a diamond shape divided in two by a horizontally aligned wavy band with the top portion in the color blue and the bottom portion in the color orange, to the right of this design is the wording "TRUVADA" displayed in large letters on a single line in the color gray, the wording "EMTRICITABINE 200 MG / TENOFOVIR" appears below this on a single line in the color gray, "DISOPROXIL FUMARATE 300 MG TABLETS" appears below this on a single line in the color gray and "FOR PREP PRE-EXPOSURE PROPHYLAXIS" appears below this on a single line in the color gray with the wording "FOR PRE-EXPOSURE PROPHYLAXIS" in the color blue and the wording "PREP" in the color white inside a blue oval.
Pseudo MarkTRUVADA EMTRICITABINE TWO HUNDRED MG / TENOFOVIR DISOPROXIL FUMARATE THREE HUNDRED MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Indication of Colors claimedThe color(s) blue, orange, gray and white is/are claimed as a feature of the mark.
Goods and ServicesPromoting public awareness on the prevention of HIV infection
Goods and ServicesMedical services, namely, providing information regarding the prevention of HIV infection
NOT AVAILABLE"EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 9, 2016
Primary Code035
First Use Anywhere DateSaturday, March 31, 2018
First Use In Commerce DateSaturday, March 31, 2018
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 9, 2016
Primary Code044
First Use Anywhere DateSaturday, March 31, 2018
First Use In Commerce DateSaturday, March 31, 2018

Trademark Owner History

Party NameGilead Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Wednesday, November 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 8, 2016NEW APPLICATION ENTERED
Thursday, November 10, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, January 14, 2017ASSIGNED TO EXAMINER
Wednesday, January 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2017NON-FINAL ACTION WRITTEN
Monday, May 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, June 22, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, June 22, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, June 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2017ASSIGNED TO LIE
Friday, June 23, 2017EXAMINER'S AMENDMENT ENTERED
Friday, June 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 30, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 18, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 7, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 7, 2017WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Thursday, August 10, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, August 10, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, August 10, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 10, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, October 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 22, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, March 22, 2018USE AMENDMENT FILED
Monday, April 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 11, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 8, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 8, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 31, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 1, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, October 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 7, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 12, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

prep exposure prophylaxis tablets fumarate emtricitabine tenofovir disoproxil truvada prevention infection providing information regarding namely medical public awareness promoting